We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+25.12%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$601M
AUM Growth
+$42.3M
Cap. Flow
-$26.9M
Cap. Flow %
-4.47%
Top 10 Hldgs %
8.35%
Holding
415
New
119
Increased
62
Reduced
89
Closed
133

Top Buys

Rank Stock Value
1
RPD icon
Rapid7
RPD
+$4.22M
2
HRTX icon
Heron Therapeutics
HRTX
+$4.08M
3
EHC icon
Encompass Health
EHC
+$3.91M
4
FICO icon
Fair Isaac
FICO
+$3.84M
5
PGTI
PGT, Inc.
PGTI
+$3.83M

Top Sells

Rank Stock Value
1
WGO icon
Winnebago Industries
WGO
+$5.14M
2
CBIO
Crescent Biopharma
CBIO
+$4.82M
3
CONN
Conn's Inc.
CONN
+$4.25M
4
SEI
Solaris Energy Infrastructure
SEI
+$3.91M
5
ESIO
Electro Scientific Industries
ESIO
+$3.87M

Sector Composition

Rank Sector Weight
1 Healthcare 31.95%
2 Technology 26.81%
3 Industrials 16.38%
4 Consumer Discretionary 8.04%
5 Financials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
$3.95M 0.66%
+375,205
New +$3.71M
FIVN icon
27
FIVE9
FIVN
$2.11B
$3.92M 0.65%
131,738
+98,596
+297% +$2.7M
FICO icon
28
Fair Isaac
FICO
$24.3B
$3.89M 0.65%
+22,992
New +$3.84M
VIRT icon
29
Virtu Financial
VIRT
$5.11B
$3.85M 0.64%
+116,535
New +$3.02M
MED icon
30
Medifast
MED
$109M
$3.81M 0.63%
40,773
-10,945
-21% -$818K
COLL icon
31
Collegium Pharmaceutical
COLL
$1.15B
$3.8M 0.63%
+148,629
New +$3.54M
EFOR
32
Everforth Inc
EFOR
$1.17B
$3.79M 0.63%
+46,247
New +$3.46M
IOVA icon
33
Iovance Biotherapeutics
IOVA
$1.82B
$3.77M 0.63%
+223,029
New +$3.38M
WIFI
34
DELISTED
Boingo Wireless, Inc.
WIFI
$3.76M 0.63%
151,661
-4,316
-3% -$106K
KMG
35
DELISTED
KMG Chemicals Inc
KMG
$3.68M 0.61%
61,370
+3,464
+6% +$216K
GTHX
36
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.65M 0.61%
+98,551
New +$2.63M
ETSY icon
37
Etsy
ETSY
$7.75B
$3.61M 0.6%
+128,757
New +$2.89M
PLNT icon
38
Planet Fitness
PLNT
$4.42B
$3.61M 0.6%
95,498
+7,469
+8% +$262K
PVLA
39
Palvella Therapeutics
PVLA
$1.99B
$3.56M 0.59%
6,518
+5,198
+394% +$3.22M
BOOT icon
40
Boot Barn
BOOT
$4.51B
$3.53M 0.59%
199,086
-111,104
-36% -$2M
HUBS icon
41
HubSpot
HUBS
$12.2B
$3.51M 0.58%
+32,377
New +$3.37M
RVNC
42
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.48M 0.58%
113,096
+5,763
+5% +$185K
LGND icon
43
Ligand Pharmaceuticals
LGND
$5.76B
$3.47M 0.58%
+33,690
New +$3.33M
NBIX icon
44
Neurocrine Biosciences
NBIX
$16.8B
$3.44M 0.57%
41,529
+3,249
+8% +$274K
THC icon
45
Tenet Healthcare
THC
$20.5B
$3.44M 0.57%
+141,636
New +$2.82M
PAYC icon
46
Paycom
PAYC
$7.64B
$3.42M 0.57%
31,881
+2,482
+8% +$238K
KFY icon
47
Korn Ferry
KFY
$4.18B
$3.4M 0.57%
+65,904
New +$2.93M
LITE icon
48
Lumentum
LITE
$55.5B
$3.38M 0.56%
+52,905
New +$3.04M
KAI icon
49
Kadant
KAI
$3.63B
$3.35M 0.56%
35,408
-3,435
-9% -$337K
RNG icon
50
RingCentral
RNG
$4.66B
$3.31M 0.55%
52,193
-11,635
-18% -$681K
1
2
3 4 5

Similar funds

NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
RB
Rodgers Brothers Harmony, Pennsylvania $866M AUM 30.05% 1-Year Est. Return
BGC
Blue Grotto Capital Atlanta, Georgia $868M AUM 56.95% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return

EAM Investors's Q1 2018 Portfolio in Review

As of Q1 2018, EAM Investors held 415 positions worth $601M, up 7.6% from $558M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

EAM Investors withdrew a net $26.9M in Q1 2018, closing 133 positions and reducing 89 holdings. Its most notable exit was Winnebago Industries, an estimated $5.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Rapid7 worth $4.47M.

  • EAM Investors's largest Q1 2018 buy was Rapid7: 174,796 shares worth $4.47M.
  • EAM Investors added most to Palvella Therapeutics in Q1 2018, an estimated $3.22M increase.
  • EAM Investors's biggest Q1 2018 reduction was The Shyft Group, cutting an estimated $3.43M.
  • EAM Investors fully exited Winnebago Industries in Q1 2018, selling an estimated $5.14M.
  • EAM Investors's ten largest holdings make up 8.4% of its $601M portfolio in Q1 2018.
  • EAM Investors opened 119 new positions and closed 133 in Q1 2018.
  • EAM Investors's portfolio value rose 7.6% quarter-over-quarter to $601M.

Based on EAM Investors's 13F filing for Q1 2018, filed 14 May 2018.